4
Featured
Impact 6/10
Insider Transaction
$REGN · REGENERON PHARMACEUTICALS, INC.
Summary
Form 4 shows director George Sing exercised options for 15,269 shares (at $376.69 and $380.95) and sold 21,129 shares across nine transactions at prices from $960.57 to $970.18, totaling $20,376,358.34. He retains 25,147 shares after the sales. No 10b5-1 plan was indicated.
Key points
- Total sale proceeds: $20,376,358.34 across 21,129 shares.
- Option exercises acquired 15,269 shares at $376.69 and $380.95.
- Sales executed at $960.57–$970.18 per share.
- Post-transaction ownership: 25,147 shares.
- No 10b5-1 trading plan was indicated.
Insider transaction
InsiderSING GEORGE L (Director)
Actionsale
Shares7,073
Price$965.38
Total value$6,828,132.74
Owned after25,147
Market impact
Extended-hours last trade $933.50, +0.30% vs regular close; routine director sale, no notable reaction.
Why this matters
A director monetized $20.4M in options, a routine but notable insider-sale disclosure.
Sector context
_Not applicable._
Risk factors
Routine director option exercise and sale; no distinct risk signal beyond standard insider-selling optics.
Related tickers
Related & recent SEC filings